Suchergebnisse - "Fibrinolytic Agents"

PubPharm (3.881)

1

Tenecteplase versus alteplase for acute ischemic stroke : a systematic review and meta-analysis of randomized and non-randomized studies

enthalten in: Journal of neurology | 2024

von Ma, Y. | Xiang, H. | Busse, J. | +13

2

Histone content, and thus DNA content, is associated with differential in vitro lysis of acute ischemic stroke clots

enthalten in: Journal of thrombosis and haemostasis : JTH | 2024

von Akkipeddi, S. | Rahmani, R. | Ellens, N. | +11

3

Association of Time to Thrombolysis With Early Reperfusion After Alteplase and Tenecteplase in Patients With Large Vessel Occlusion

enthalten in: Neurology | 2024

von Yogendrakumar, V. | Beharry, J. | Churilov, L. | +20

4

Time to Treatment With Intravenous Thrombolysis Before Thrombectomy and Functional Outcomes in Acute Ischemic Stroke : A Meta-Analysis

enthalten in: JAMA | 2024

von Kaesmacher, J. | Cavalcante, F. | Kappelhof, M. | +89

5

Evaluation of clinical efficacy of streptokinase by comparison with the thrombolytic agent on animal model

enthalten in: Brazilian journal of biology = Revista brasleira de biologia | 2024

von Yousaf, S. | Arshad, M. | Harraz, F. | +4

6

Deterioration free discharge comparison of andexanet-alfa and prothrombin complex concentrates (PCC) for reversal of factor Xa inhibitor associated bleeds

enthalten in: Journal of thrombosis and thrombolysis | 2023

von Keinath, J. | Lekura, J. | Hauser, C. | +4

7

Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke : The ARAMIS Randomized Clinical Trial

enthalten in: JAMA | 2023

von Chen, H. | Cui, Y. | Zhou, Z. | +41

CommentIn: Ann Intern Med. 2023 Oct;176(10):JC110. - PMID 37782921

8

Tenecteplase Treatment and Thrombus Characteristics Associated With Early Reperfusion : An EXTEND-IA TNK Trials Analysis

enthalten in: Stroke | 2023

von Yogendrakumar, V. | Churilov, L. | Guha, P. | +32

9

Intravenous tenecteplase compared with alteplase for acute ischemic stroke in Canada (AcT) : a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial

enthalten in: CJEM | 2023

von Ferguson, E. | Yadav, K.

10

Comparison of Managing Factor Xa Inhibitor to Unfractionated Heparin Transitions by aPTT Versus a Treatment Guideline Utilizing Heparin Anti-Xa Levels

enthalten in: The Annals of pharmacotherapy | 2022

von Dingus, S. | Smith, A. | Dager, W. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[389]